Opinion
The Tobacco/Nicotine Industrial Complex: The Impact of Revenue on Tobacco Harm Reduction Policies
A complex web of economic forces heavily influenced by divergent state tax policies across the United States sustains the traditional cigarette industry’s dominance despite the rise of reduced-risk ...
The Well News on MSNOpinion
It's FDA's Moment to Lead With Purpose on Nicotine
Why Timely, Science-Based FDA Action on Nicotine Is Critical for Harm Reduction The U.S. tobacco and nicotine marketplace is ...
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence ...
23h
Achieve Life Sciences outlines expedited FDA review for cytisinicline and targets Q3/Q4 2026 launch
Discover key Q3 2025 insights from Achieve Life Sciences as they expedite cytisinicline’s FDA approval for nicotine dependence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback